nodes	percent_of_prediction	percent_of_DWPC	metapath
Epoprostenol—CYP2C9—brain cancer	0.713	1	CbGaD
Epoprostenol—PTGIS—Prostaglandin Synthesis and Regulation—S100A6—brain cancer	0.00826	0.103	CbGpPWpGaD
Epoprostenol—PTGIS—endothelium—brain cancer	0.00779	0.126	CbGeAlD
Epoprostenol—PTGIS—blood vessel—brain cancer	0.00718	0.116	CbGeAlD
Epoprostenol—PTGIR—Prostaglandin Synthesis and Regulation—S100A6—brain cancer	0.00605	0.0757	CbGpPWpGaD
Epoprostenol—PTGER1—Prostaglandin Synthesis and Regulation—S100A6—brain cancer	0.00605	0.0757	CbGpPWpGaD
Epoprostenol—PTGIS—Prostaglandin Synthesis and Regulation—S100A10—brain cancer	0.00573	0.0717	CbGpPWpGaD
Epoprostenol—PTGIR—endothelium—brain cancer	0.00447	0.0723	CbGeAlD
Epoprostenol—PTGER1—Prostaglandin Synthesis and Regulation—S100A10—brain cancer	0.00419	0.0525	CbGpPWpGaD
Epoprostenol—PTGIR—Prostaglandin Synthesis and Regulation—S100A10—brain cancer	0.00419	0.0525	CbGpPWpGaD
Epoprostenol—PTGIR—blood vessel—brain cancer	0.00413	0.0666	CbGeAlD
Epoprostenol—PTGIR—hindbrain—brain cancer	0.00393	0.0636	CbGeAlD
Epoprostenol—PTGIS—Arachidonic acid metabolism—CYP2C9—brain cancer	0.00315	0.0395	CbGpPWpGaD
Epoprostenol—Treprostinil—CYP2C9—brain cancer	0.00313	1	CrCbGaD
Epoprostenol—PTGIS—Cytochrome P450 - arranged by substrate type—CYP2C9—brain cancer	0.00273	0.0341	CbGpPWpGaD
Epoprostenol—PTGIR—brainstem—brain cancer	0.00226	0.0364	CbGeAlD
Epoprostenol—PTGIS—Phase 1 - Functionalization of compounds—CYP2C9—brain cancer	0.00221	0.0277	CbGpPWpGaD
Epoprostenol—PTGIS—endocrine gland—brain cancer	0.0022	0.0355	CbGeAlD
Epoprostenol—PTGIS—head—brain cancer	0.00217	0.0351	CbGeAlD
Epoprostenol—PTGER1—endocrine gland—brain cancer	0.00204	0.033	CbGeAlD
Epoprostenol—PTGER1—head—brain cancer	0.00202	0.0326	CbGeAlD
Epoprostenol—PTGIR—telencephalon—brain cancer	0.002	0.0323	CbGeAlD
Epoprostenol—PTGIS—central nervous system—brain cancer	0.00198	0.032	CbGeAlD
Epoprostenol—P2RY12—endocrine gland—brain cancer	0.00198	0.032	CbGeAlD
Epoprostenol—P2RY12—head—brain cancer	0.00195	0.0316	CbGeAlD
Epoprostenol—PTGIR—Thromboxane A2 receptor signaling—TGM2—brain cancer	0.00189	0.0237	CbGpPWpGaD
Epoprostenol—PTGER1—central nervous system—brain cancer	0.00184	0.0297	CbGeAlD
Epoprostenol—P2RY12—central nervous system—brain cancer	0.00178	0.0288	CbGeAlD
Epoprostenol—PTGIR—gonad—brain cancer	0.00167	0.027	CbGeAlD
Epoprostenol—PTGIS—brain—brain cancer	0.00157	0.0254	CbGeAlD
Epoprostenol—P2RY12—brain—brain cancer	0.00142	0.0229	CbGeAlD
Epoprostenol—PTGIR—spinal cord—brain cancer	0.0014	0.0227	CbGeAlD
Epoprostenol—PTGIR—endocrine gland—brain cancer	0.00126	0.0204	CbGeAlD
Epoprostenol—PTGIR—head—brain cancer	0.00125	0.0201	CbGeAlD
Epoprostenol—PTGIS—Biological oxidations—CYP2C9—brain cancer	0.00117	0.0147	CbGpPWpGaD
Epoprostenol—PTGIR—central nervous system—brain cancer	0.00114	0.0184	CbGeAlD
Epoprostenol—PTGIR—cerebellum—brain cancer	0.00111	0.018	CbGeAlD
Epoprostenol—P2RY12—Platelet activation, signaling and aggregation—MPL—brain cancer	0.000961	0.012	CbGpPWpGaD
Epoprostenol—PTGIR—brain—brain cancer	0.000903	0.0146	CbGeAlD
Epoprostenol—PTGIR—Platelet homeostasis—TRPC6—brain cancer	0.000901	0.0113	CbGpPWpGaD
Epoprostenol—Body temperature increased—Carboplatin—brain cancer	0.00068	0.00478	CcSEcCtD
Epoprostenol—Haemoglobin—Procarbazine—brain cancer	0.000675	0.00476	CcSEcCtD
Epoprostenol—Haemorrhage—Procarbazine—brain cancer	0.000672	0.00473	CcSEcCtD
Epoprostenol—Decreased appetite—Lomustine—brain cancer	0.000654	0.0046	CcSEcCtD
Epoprostenol—Hepatic failure—Temozolomide—brain cancer	0.000654	0.0046	CcSEcCtD
Epoprostenol—Flushing—Procarbazine—brain cancer	0.000624	0.00439	CcSEcCtD
Epoprostenol—Thirst—Temozolomide—brain cancer	0.000617	0.00434	CcSEcCtD
Epoprostenol—Pancytopenia—Hydroxyurea—brain cancer	0.000617	0.00434	CcSEcCtD
Epoprostenol—Chills—Procarbazine—brain cancer	0.000603	0.00425	CcSEcCtD
Epoprostenol—Body temperature increased—Lomustine—brain cancer	0.000595	0.00419	CcSEcCtD
Epoprostenol—Infestation—Hydroxyurea—brain cancer	0.000579	0.00408	CcSEcCtD
Epoprostenol—Infestation NOS—Hydroxyurea—brain cancer	0.000579	0.00408	CcSEcCtD
Epoprostenol—Tension—Procarbazine—brain cancer	0.000574	0.00404	CcSEcCtD
Epoprostenol—Nervousness—Procarbazine—brain cancer	0.000568	0.004	CcSEcCtD
Epoprostenol—Sepsis—Etoposide—brain cancer	0.000562	0.00396	CcSEcCtD
Epoprostenol—PTGIR—Thromboxane A2 receptor signaling—PIK3CG—brain cancer	0.000559	0.007	CbGpPWpGaD
Epoprostenol—Tremor—Procarbazine—brain cancer	0.000548	0.00386	CcSEcCtD
Epoprostenol—Anaemia—Procarbazine—brain cancer	0.000541	0.00381	CcSEcCtD
Epoprostenol—Syncope—Procarbazine—brain cancer	0.000525	0.00369	CcSEcCtD
Epoprostenol—Haemoglobin—Hydroxyurea—brain cancer	0.000523	0.00368	CcSEcCtD
Epoprostenol—Haemorrhage—Hydroxyurea—brain cancer	0.00052	0.00366	CcSEcCtD
Epoprostenol—Loss of consciousness—Procarbazine—brain cancer	0.000514	0.00362	CcSEcCtD
Epoprostenol—Abdominal distension—Temozolomide—brain cancer	0.000511	0.0036	CcSEcCtD
Epoprostenol—Cough—Procarbazine—brain cancer	0.000511	0.00359	CcSEcCtD
Epoprostenol—Pancytopenia—Carmustine—brain cancer	0.000499	0.00351	CcSEcCtD
Epoprostenol—Arthralgia—Procarbazine—brain cancer	0.000498	0.00351	CcSEcCtD
Epoprostenol—Myalgia—Procarbazine—brain cancer	0.000498	0.00351	CcSEcCtD
Epoprostenol—Anxiety—Procarbazine—brain cancer	0.000496	0.00349	CcSEcCtD
Epoprostenol—P2RY12—Hemostasis—MPL—brain cancer	0.000496	0.00621	CbGpPWpGaD
Epoprostenol—P2RY12—GPCR ligand binding—PTCH2—brain cancer	0.000494	0.00619	CbGpPWpGaD
Epoprostenol—Dry mouth—Procarbazine—brain cancer	0.000487	0.00343	CcSEcCtD
Epoprostenol—Pancytopenia—Temozolomide—brain cancer	0.000482	0.00339	CcSEcCtD
Epoprostenol—Cardiac failure—Etoposide—brain cancer	0.000482	0.00339	CcSEcCtD
Epoprostenol—Confusional state—Procarbazine—brain cancer	0.000481	0.00339	CcSEcCtD
Epoprostenol—Vomiting—Lomustine—brain cancer	0.000478	0.00337	CcSEcCtD
Epoprostenol—Oedema—Procarbazine—brain cancer	0.000477	0.00336	CcSEcCtD
Epoprostenol—P2RY12—Hemostasis—S100A10—brain cancer	0.000475	0.00595	CbGpPWpGaD
Epoprostenol—Infection—Procarbazine—brain cancer	0.000474	0.00334	CcSEcCtD
Epoprostenol—Angiopathy—Hydroxyurea—brain cancer	0.000472	0.00332	CcSEcCtD
Epoprostenol—Pneumonia—Carmustine—brain cancer	0.000471	0.00332	CcSEcCtD
Epoprostenol—Shock—Procarbazine—brain cancer	0.00047	0.00331	CcSEcCtD
Epoprostenol—Thrombocytopenia—Procarbazine—brain cancer	0.000467	0.00329	CcSEcCtD
Epoprostenol—Depression—Carmustine—brain cancer	0.000467	0.00329	CcSEcCtD
Epoprostenol—Chills—Hydroxyurea—brain cancer	0.000467	0.00329	CcSEcCtD
Epoprostenol—Tachycardia—Procarbazine—brain cancer	0.000466	0.00328	CcSEcCtD
Epoprostenol—Hyperhidrosis—Procarbazine—brain cancer	0.000462	0.00325	CcSEcCtD
Epoprostenol—Weight decreased—Temozolomide—brain cancer	0.000459	0.00323	CcSEcCtD
Epoprostenol—PTGIR—Hemostasis—MPL—brain cancer	0.000456	0.00571	CbGpPWpGaD
Epoprostenol—Urinary tract infection—Carmustine—brain cancer	0.000455	0.0032	CcSEcCtD
Epoprostenol—Pneumonia—Temozolomide—brain cancer	0.000455	0.0032	CcSEcCtD
Epoprostenol—Anorexia—Procarbazine—brain cancer	0.000455	0.0032	CcSEcCtD
Epoprostenol—PTGIR—GPCR ligand binding—PTCH2—brain cancer	0.000455	0.00569	CbGpPWpGaD
Epoprostenol—PTGER1—GPCR ligand binding—PTCH2—brain cancer	0.000455	0.00569	CbGpPWpGaD
Epoprostenol—Infestation NOS—Temozolomide—brain cancer	0.000453	0.00319	CcSEcCtD
Epoprostenol—Infestation—Temozolomide—brain cancer	0.000453	0.00319	CcSEcCtD
Epoprostenol—Depression—Temozolomide—brain cancer	0.000451	0.00318	CcSEcCtD
Epoprostenol—CYP2C9—endocrine gland—brain cancer	0.000451	0.00729	CbGeAlD
Epoprostenol—PTGIS—Metabolism of lipids and lipoproteins—CYP2C9—brain cancer	0.000451	0.00564	CbGpPWpGaD
Epoprostenol—PTGER1—G alpha (q) signalling events—TRPC6—brain cancer	0.000448	0.00561	CbGpPWpGaD
Epoprostenol—Nausea—Lomustine—brain cancer	0.000447	0.00314	CcSEcCtD
Epoprostenol—Hypotension—Procarbazine—brain cancer	0.000446	0.00314	CcSEcCtD
Epoprostenol—PTGIS—Adipogenesis—IRS2—brain cancer	0.000441	0.00552	CbGpPWpGaD
Epoprostenol—Urinary tract infection—Temozolomide—brain cancer	0.00044	0.0031	CcSEcCtD
Epoprostenol—PTGIR—Hemostasis—S100A10—brain cancer	0.000437	0.00548	CbGpPWpGaD
Epoprostenol—Musculoskeletal discomfort—Procarbazine—brain cancer	0.000435	0.00306	CcSEcCtD
Epoprostenol—P2RY12—GPCR downstream signaling—OR14C36—brain cancer	0.000433	0.00543	CbGpPWpGaD
Epoprostenol—P2RY12—GPCR downstream signaling—OR4C12—brain cancer	0.000433	0.00543	CbGpPWpGaD
Epoprostenol—Insomnia—Procarbazine—brain cancer	0.000432	0.00304	CcSEcCtD
Epoprostenol—Paraesthesia—Procarbazine—brain cancer	0.000429	0.00302	CcSEcCtD
Epoprostenol—P2RY12—Platelet activation, signaling and aggregation—TRPC6—brain cancer	0.000426	0.00533	CbGpPWpGaD
Epoprostenol—Sinusitis—Temozolomide—brain cancer	0.000425	0.00299	CcSEcCtD
Epoprostenol—Somnolence—Procarbazine—brain cancer	0.000424	0.00299	CcSEcCtD
Epoprostenol—Haemoglobin—Carmustine—brain cancer	0.000423	0.00297	CcSEcCtD
Epoprostenol—Haemorrhage—Carmustine—brain cancer	0.00042	0.00296	CcSEcCtD
Epoprostenol—Anaemia—Hydroxyurea—brain cancer	0.000418	0.00295	CcSEcCtD
Epoprostenol—Hypoaesthesia—Carmustine—brain cancer	0.000418	0.00295	CcSEcCtD
Epoprostenol—Decreased appetite—Procarbazine—brain cancer	0.000415	0.00292	CcSEcCtD
Epoprostenol—Oedema peripheral—Carmustine—brain cancer	0.000414	0.00292	CcSEcCtD
Epoprostenol—Connective tissue disorder—Carmustine—brain cancer	0.000413	0.00291	CcSEcCtD
Epoprostenol—Fatigue—Procarbazine—brain cancer	0.000412	0.0029	CcSEcCtD
Epoprostenol—Haemoglobin—Temozolomide—brain cancer	0.000408	0.00287	CcSEcCtD
Epoprostenol—Pain—Procarbazine—brain cancer	0.000408	0.00287	CcSEcCtD
Epoprostenol—Constipation—Procarbazine—brain cancer	0.000408	0.00287	CcSEcCtD
Epoprostenol—Haemorrhage—Temozolomide—brain cancer	0.000406	0.00286	CcSEcCtD
Epoprostenol—Hypoaesthesia—Temozolomide—brain cancer	0.000404	0.00285	CcSEcCtD
Epoprostenol—Pharyngitis—Temozolomide—brain cancer	0.000403	0.00284	CcSEcCtD
Epoprostenol—PTGER1—Gastrin-CREB signalling pathway via PKC and MAPK—TRPC6—brain cancer	0.0004	0.00502	CbGpPWpGaD
Epoprostenol—Oedema peripheral—Temozolomide—brain cancer	0.0004	0.00282	CcSEcCtD
Epoprostenol—Connective tissue disorder—Temozolomide—brain cancer	0.000399	0.00281	CcSEcCtD
Epoprostenol—PTGIR—GPCR downstream signaling—OR14C36—brain cancer	0.000399	0.00499	CbGpPWpGaD
Epoprostenol—PTGER1—GPCR downstream signaling—OR4C12—brain cancer	0.000399	0.00499	CbGpPWpGaD
Epoprostenol—PTGIR—GPCR downstream signaling—OR4C12—brain cancer	0.000399	0.00499	CbGpPWpGaD
Epoprostenol—PTGER1—GPCR downstream signaling—OR14C36—brain cancer	0.000399	0.00499	CbGpPWpGaD
Epoprostenol—P2RY12—Signaling by GPCR—OR14C36—brain cancer	0.000393	0.00493	CbGpPWpGaD
Epoprostenol—P2RY12—Signaling by GPCR—OR4C12—brain cancer	0.000393	0.00493	CbGpPWpGaD
Epoprostenol—Gastrointestinal pain—Procarbazine—brain cancer	0.00039	0.00275	CcSEcCtD
Epoprostenol—Flushing—Carmustine—brain cancer	0.00039	0.00275	CcSEcCtD
Epoprostenol—Pancytopenia—Etoposide—brain cancer	0.000386	0.00272	CcSEcCtD
Epoprostenol—Unspecified disorder of skin and subcutaneous tissue—Hydroxyurea—brain cancer	0.000383	0.00269	CcSEcCtD
Epoprostenol—Urticaria—Procarbazine—brain cancer	0.000379	0.00267	CcSEcCtD
Epoprostenol—Body temperature increased—Procarbazine—brain cancer	0.000377	0.00266	CcSEcCtD
Epoprostenol—Abdominal pain—Procarbazine—brain cancer	0.000377	0.00266	CcSEcCtD
Epoprostenol—Cardiac disorder—Temozolomide—brain cancer	0.000377	0.00265	CcSEcCtD
Epoprostenol—Flushing—Temozolomide—brain cancer	0.000377	0.00265	CcSEcCtD
Epoprostenol—Oedema—Hydroxyurea—brain cancer	0.00037	0.0026	CcSEcCtD
Epoprostenol—Angiopathy—Temozolomide—brain cancer	0.000369	0.0026	CcSEcCtD
Epoprostenol—Mental disorder—Carmustine—brain cancer	0.000368	0.00259	CcSEcCtD
Epoprostenol—Infection—Hydroxyurea—brain cancer	0.000367	0.00258	CcSEcCtD
Epoprostenol—Mediastinal disorder—Temozolomide—brain cancer	0.000366	0.00258	CcSEcCtD
Epoprostenol—Chills—Temozolomide—brain cancer	0.000365	0.00257	CcSEcCtD
Epoprostenol—Pneumonia—Etoposide—brain cancer	0.000364	0.00256	CcSEcCtD
Epoprostenol—Nervous system disorder—Hydroxyurea—brain cancer	0.000362	0.00255	CcSEcCtD
Epoprostenol—Infestation—Etoposide—brain cancer	0.000362	0.00255	CcSEcCtD
Epoprostenol—Infestation NOS—Etoposide—brain cancer	0.000362	0.00255	CcSEcCtD
Epoprostenol—PTGIR—Signaling by GPCR—OR14C36—brain cancer	0.000362	0.00453	CbGpPWpGaD
Epoprostenol—PTGER1—Signaling by GPCR—OR14C36—brain cancer	0.000362	0.00453	CbGpPWpGaD
Epoprostenol—PTGER1—Signaling by GPCR—OR4C12—brain cancer	0.000362	0.00453	CbGpPWpGaD
Epoprostenol—PTGIR—Signaling by GPCR—OR4C12—brain cancer	0.000362	0.00453	CbGpPWpGaD
Epoprostenol—Thrombocytopenia—Hydroxyurea—brain cancer	0.000362	0.00255	CcSEcCtD
Epoprostenol—Skin disorder—Hydroxyurea—brain cancer	0.000359	0.00253	CcSEcCtD
Epoprostenol—Acute coronary syndrome—Etoposide—brain cancer	0.000357	0.00251	CcSEcCtD
Epoprostenol—Mental disorder—Temozolomide—brain cancer	0.000356	0.00251	CcSEcCtD
Epoprostenol—Myocardial infarction—Etoposide—brain cancer	0.000355	0.0025	CcSEcCtD
Epoprostenol—PTGIS—Disease—DTX2—brain cancer	0.000355	0.00444	CbGpPWpGaD
Epoprostenol—Back pain—Carmustine—brain cancer	0.000354	0.00249	CcSEcCtD
Epoprostenol—Anorexia—Hydroxyurea—brain cancer	0.000352	0.00248	CcSEcCtD
Epoprostenol—Hypersensitivity—Procarbazine—brain cancer	0.000352	0.00248	CcSEcCtD
Epoprostenol—Tremor—Carmustine—brain cancer	0.000343	0.00241	CcSEcCtD
Epoprostenol—Asthenia—Procarbazine—brain cancer	0.000343	0.00241	CcSEcCtD
Epoprostenol—Back pain—Temozolomide—brain cancer	0.000342	0.00241	CcSEcCtD
Epoprostenol—Anaemia—Carmustine—brain cancer	0.000338	0.00238	CcSEcCtD
Epoprostenol—Pruritus—Procarbazine—brain cancer	0.000338	0.00238	CcSEcCtD
Epoprostenol—Agitation—Carmustine—brain cancer	0.000336	0.00237	CcSEcCtD
Epoprostenol—P2RY12—Hemostasis—BSG—brain cancer	0.000335	0.00419	CbGpPWpGaD
Epoprostenol—Tremor—Temozolomide—brain cancer	0.000331	0.00233	CcSEcCtD
Epoprostenol—PTGIS—Metabolism of lipids and lipoproteins—IDH1—brain cancer	0.000329	0.00413	CbGpPWpGaD
Epoprostenol—Dyspnoea—Hydroxyurea—brain cancer	0.000329	0.00232	CcSEcCtD
Epoprostenol—Somnolence—Hydroxyurea—brain cancer	0.000329	0.00231	CcSEcCtD
Epoprostenol—Anaemia—Temozolomide—brain cancer	0.000327	0.0023	CcSEcCtD
Epoprostenol—Diarrhoea—Procarbazine—brain cancer	0.000327	0.0023	CcSEcCtD
Epoprostenol—Dyspepsia—Hydroxyurea—brain cancer	0.000325	0.00229	CcSEcCtD
Epoprostenol—Agitation—Temozolomide—brain cancer	0.000325	0.00229	CcSEcCtD
Epoprostenol—Hypoaesthesia—Etoposide—brain cancer	0.000324	0.00228	CcSEcCtD
Epoprostenol—Decreased appetite—Hydroxyurea—brain cancer	0.000321	0.00226	CcSEcCtD
Epoprostenol—Gastrointestinal disorder—Hydroxyurea—brain cancer	0.000319	0.00225	CcSEcCtD
Epoprostenol—P2RY12—Platelet activation, signaling and aggregation—VAV1—brain cancer	0.000319	0.00399	CbGpPWpGaD
Epoprostenol—Fatigue—Hydroxyurea—brain cancer	0.000319	0.00224	CcSEcCtD
Epoprostenol—Constipation—Hydroxyurea—brain cancer	0.000316	0.00222	CcSEcCtD
Epoprostenol—Pain—Hydroxyurea—brain cancer	0.000316	0.00222	CcSEcCtD
Epoprostenol—Dizziness—Procarbazine—brain cancer	0.000316	0.00222	CcSEcCtD
Epoprostenol—Palpitations—Temozolomide—brain cancer	0.000313	0.0022	CcSEcCtD
Epoprostenol—Myalgia—Carmustine—brain cancer	0.000312	0.00219	CcSEcCtD
Epoprostenol—Chest pain—Carmustine—brain cancer	0.000312	0.00219	CcSEcCtD
Epoprostenol—Anxiety—Carmustine—brain cancer	0.000311	0.00219	CcSEcCtD
Epoprostenol—Cough—Temozolomide—brain cancer	0.000309	0.00217	CcSEcCtD
Epoprostenol—PTGIR—Hemostasis—BSG—brain cancer	0.000308	0.00386	CbGpPWpGaD
Epoprostenol—Vomiting—Procarbazine—brain cancer	0.000304	0.00214	CcSEcCtD
Epoprostenol—Cardiac disorder—Etoposide—brain cancer	0.000302	0.00212	CcSEcCtD
Epoprostenol—Flushing—Etoposide—brain cancer	0.000302	0.00212	CcSEcCtD
Epoprostenol—Confusional state—Carmustine—brain cancer	0.000301	0.00212	CcSEcCtD
Epoprostenol—Arthralgia—Temozolomide—brain cancer	0.000301	0.00212	CcSEcCtD
Epoprostenol—Myalgia—Temozolomide—brain cancer	0.000301	0.00212	CcSEcCtD
Epoprostenol—Rash—Procarbazine—brain cancer	0.000301	0.00212	CcSEcCtD
Epoprostenol—PTGIR—Thromboxane A2 receptor signaling—EGFR—brain cancer	0.000301	0.00377	CbGpPWpGaD
Epoprostenol—Dermatitis—Procarbazine—brain cancer	0.000301	0.00212	CcSEcCtD
Epoprostenol—Anxiety—Temozolomide—brain cancer	0.0003	0.00211	CcSEcCtD
Epoprostenol—Headache—Procarbazine—brain cancer	0.000299	0.00211	CcSEcCtD
Epoprostenol—Unspecified disorder of skin and subcutaneous tissue—Temozolomide—brain cancer	0.000299	0.00211	CcSEcCtD
Epoprostenol—Oedema—Carmustine—brain cancer	0.000299	0.0021	CcSEcCtD
Epoprostenol—Infection—Carmustine—brain cancer	0.000297	0.00209	CcSEcCtD
Epoprostenol—Angiopathy—Etoposide—brain cancer	0.000295	0.00208	CcSEcCtD
Epoprostenol—Dry mouth—Temozolomide—brain cancer	0.000295	0.00207	CcSEcCtD
Epoprostenol—Mediastinal disorder—Etoposide—brain cancer	0.000293	0.00206	CcSEcCtD
Epoprostenol—Thrombocytopenia—Carmustine—brain cancer	0.000292	0.00206	CcSEcCtD
Epoprostenol—Body temperature increased—Hydroxyurea—brain cancer	0.000292	0.00206	CcSEcCtD
Epoprostenol—Chills—Etoposide—brain cancer	0.000292	0.00205	CcSEcCtD
Epoprostenol—Tachycardia—Carmustine—brain cancer	0.000292	0.00205	CcSEcCtD
Epoprostenol—Confusional state—Temozolomide—brain cancer	0.000291	0.00205	CcSEcCtD
Epoprostenol—Oedema—Temozolomide—brain cancer	0.000289	0.00203	CcSEcCtD
Epoprostenol—Anaphylactic shock—Temozolomide—brain cancer	0.000289	0.00203	CcSEcCtD
Epoprostenol—Infection—Temozolomide—brain cancer	0.000287	0.00202	CcSEcCtD
Epoprostenol—Anorexia—Carmustine—brain cancer	0.000285	0.002	CcSEcCtD
Epoprostenol—Nausea—Procarbazine—brain cancer	0.000284	0.002	CcSEcCtD
Epoprostenol—Nervous system disorder—Temozolomide—brain cancer	0.000283	0.00199	CcSEcCtD
Epoprostenol—Thrombocytopenia—Temozolomide—brain cancer	0.000283	0.00199	CcSEcCtD
Epoprostenol—Skin disorder—Temozolomide—brain cancer	0.00028	0.00197	CcSEcCtD
Epoprostenol—Hypotension—Carmustine—brain cancer	0.000279	0.00196	CcSEcCtD
Epoprostenol—Hyperhidrosis—Temozolomide—brain cancer	0.000279	0.00196	CcSEcCtD
Epoprostenol—Anorexia—Temozolomide—brain cancer	0.000275	0.00194	CcSEcCtD
Epoprostenol—Back pain—Etoposide—brain cancer	0.000274	0.00193	CcSEcCtD
Epoprostenol—Hypersensitivity—Hydroxyurea—brain cancer	0.000272	0.00192	CcSEcCtD
Epoprostenol—Musculoskeletal discomfort—Carmustine—brain cancer	0.000272	0.00192	CcSEcCtD
Epoprostenol—Muscle spasms—Etoposide—brain cancer	0.000272	0.00192	CcSEcCtD
Epoprostenol—Insomnia—Carmustine—brain cancer	0.00027	0.0019	CcSEcCtD
Epoprostenol—Paraesthesia—Carmustine—brain cancer	0.000268	0.00189	CcSEcCtD
Epoprostenol—Dyspnoea—Carmustine—brain cancer	0.000266	0.00187	CcSEcCtD
Epoprostenol—Somnolence—Carmustine—brain cancer	0.000266	0.00187	CcSEcCtD
Epoprostenol—Asthenia—Hydroxyurea—brain cancer	0.000265	0.00187	CcSEcCtD
Epoprostenol—PTGIS—Adipogenesis—CTNNB1—brain cancer	0.000264	0.00331	CbGpPWpGaD
Epoprostenol—Musculoskeletal discomfort—Temozolomide—brain cancer	0.000263	0.00185	CcSEcCtD
Epoprostenol—Anaemia—Etoposide—brain cancer	0.000262	0.00184	CcSEcCtD
Epoprostenol—Insomnia—Temozolomide—brain cancer	0.000261	0.00184	CcSEcCtD
Epoprostenol—PTGIS—Disease—HES5—brain cancer	0.00026	0.00326	CbGpPWpGaD
Epoprostenol—Decreased appetite—Carmustine—brain cancer	0.00026	0.00183	CcSEcCtD
Epoprostenol—Paraesthesia—Temozolomide—brain cancer	0.000259	0.00182	CcSEcCtD
Epoprostenol—Gastrointestinal disorder—Carmustine—brain cancer	0.000258	0.00182	CcSEcCtD
Epoprostenol—Dyspnoea—Temozolomide—brain cancer	0.000257	0.00181	CcSEcCtD
Epoprostenol—Somnolence—Temozolomide—brain cancer	0.000257	0.00181	CcSEcCtD
Epoprostenol—Constipation—Carmustine—brain cancer	0.000255	0.0018	CcSEcCtD
Epoprostenol—Pain—Carmustine—brain cancer	0.000255	0.0018	CcSEcCtD
Epoprostenol—P2RY12—GPCR ligand binding—SHH—brain cancer	0.000254	0.00319	CbGpPWpGaD
Epoprostenol—Dyspepsia—Temozolomide—brain cancer	0.000254	0.00179	CcSEcCtD
Epoprostenol—P2RY12—Signaling by GPCR—PTCH2—brain cancer	0.000253	0.00318	CbGpPWpGaD
Epoprostenol—Diarrhoea—Hydroxyurea—brain cancer	0.000253	0.00178	CcSEcCtD
Epoprostenol—Decreased appetite—Temozolomide—brain cancer	0.000251	0.00177	CcSEcCtD
Epoprostenol—Gastrointestinal disorder—Temozolomide—brain cancer	0.000249	0.00175	CcSEcCtD
Epoprostenol—Fatigue—Temozolomide—brain cancer	0.000249	0.00175	CcSEcCtD
Epoprostenol—Loss of consciousness—Etoposide—brain cancer	0.000249	0.00175	CcSEcCtD
Epoprostenol—Cough—Etoposide—brain cancer	0.000247	0.00174	CcSEcCtD
Epoprostenol—Pain—Temozolomide—brain cancer	0.000247	0.00174	CcSEcCtD
Epoprostenol—Constipation—Temozolomide—brain cancer	0.000247	0.00174	CcSEcCtD
Epoprostenol—Dizziness—Hydroxyurea—brain cancer	0.000244	0.00172	CcSEcCtD
Epoprostenol—Gastrointestinal pain—Carmustine—brain cancer	0.000244	0.00172	CcSEcCtD
Epoprostenol—P2RY12—GPCR ligand binding—SMO—brain cancer	0.000241	0.00302	CbGpPWpGaD
Epoprostenol—P2RY12—GPCR ligand binding—PTCH1—brain cancer	0.000241	0.00302	CbGpPWpGaD
Epoprostenol—Chest pain—Etoposide—brain cancer	0.000241	0.0017	CcSEcCtD
Epoprostenol—Unspecified disorder of skin and subcutaneous tissue—Etoposide—brain cancer	0.000239	0.00168	CcSEcCtD
Epoprostenol—Abdominal pain—Carmustine—brain cancer	0.000236	0.00166	CcSEcCtD
Epoprostenol—Body temperature increased—Carmustine—brain cancer	0.000236	0.00166	CcSEcCtD
Epoprostenol—Gastrointestinal pain—Temozolomide—brain cancer	0.000236	0.00166	CcSEcCtD
Epoprostenol—Vomiting—Hydroxyurea—brain cancer	0.000235	0.00165	CcSEcCtD
Epoprostenol—PTGER1—GPCR ligand binding—SHH—brain cancer	0.000234	0.00293	CbGpPWpGaD
Epoprostenol—PTGIR—GPCR ligand binding—SHH—brain cancer	0.000234	0.00293	CbGpPWpGaD
Epoprostenol—PTGIR—Signaling by GPCR—PTCH2—brain cancer	0.000233	0.00292	CbGpPWpGaD
Epoprostenol—PTGER1—Signaling by GPCR—PTCH2—brain cancer	0.000233	0.00292	CbGpPWpGaD
Epoprostenol—Rash—Hydroxyurea—brain cancer	0.000233	0.00164	CcSEcCtD
Epoprostenol—Confusional state—Etoposide—brain cancer	0.000233	0.00164	CcSEcCtD
Epoprostenol—Dermatitis—Hydroxyurea—brain cancer	0.000233	0.00164	CcSEcCtD
Epoprostenol—P2RY12—Signaling Pathways—OR14C36—brain cancer	0.000232	0.00291	CbGpPWpGaD
Epoprostenol—P2RY12—Signaling Pathways—OR4C12—brain cancer	0.000232	0.00291	CbGpPWpGaD
Epoprostenol—Headache—Hydroxyurea—brain cancer	0.000231	0.00163	CcSEcCtD
Epoprostenol—Anaphylactic shock—Etoposide—brain cancer	0.000231	0.00163	CcSEcCtD
Epoprostenol—PTGIS—Adipogenesis—STAT3—brain cancer	0.000231	0.00289	CbGpPWpGaD
Epoprostenol—Infection—Etoposide—brain cancer	0.000229	0.00162	CcSEcCtD
Epoprostenol—Urticaria—Temozolomide—brain cancer	0.000229	0.00161	CcSEcCtD
Epoprostenol—Body temperature increased—Temozolomide—brain cancer	0.000228	0.00161	CcSEcCtD
Epoprostenol—Abdominal pain—Temozolomide—brain cancer	0.000228	0.00161	CcSEcCtD
Epoprostenol—Thrombocytopenia—Etoposide—brain cancer	0.000226	0.00159	CcSEcCtD
Epoprostenol—Tachycardia—Etoposide—brain cancer	0.000225	0.00159	CcSEcCtD
Epoprostenol—Skin disorder—Etoposide—brain cancer	0.000224	0.00158	CcSEcCtD
Epoprostenol—Hyperhidrosis—Etoposide—brain cancer	0.000223	0.00157	CcSEcCtD
Epoprostenol—PTGIR—GPCR ligand binding—PTCH1—brain cancer	0.000222	0.00278	CbGpPWpGaD
Epoprostenol—PTGER1—GPCR ligand binding—SMO—brain cancer	0.000222	0.00278	CbGpPWpGaD
Epoprostenol—PTGIR—GPCR ligand binding—SMO—brain cancer	0.000222	0.00278	CbGpPWpGaD
Epoprostenol—PTGER1—GPCR ligand binding—PTCH1—brain cancer	0.000222	0.00278	CbGpPWpGaD
Epoprostenol—Anorexia—Etoposide—brain cancer	0.00022	0.00155	CcSEcCtD
Epoprostenol—Hypersensitivity—Carmustine—brain cancer	0.00022	0.00155	CcSEcCtD
Epoprostenol—Nausea—Hydroxyurea—brain cancer	0.000219	0.00155	CcSEcCtD
Epoprostenol—P2RY12—Hemostasis—TRPC6—brain cancer	0.000219	0.00275	CbGpPWpGaD
Epoprostenol—P2RY12—GPCR downstream signaling—ABR—brain cancer	0.000219	0.00274	CbGpPWpGaD
Epoprostenol—Hypotension—Etoposide—brain cancer	0.000216	0.00152	CcSEcCtD
Epoprostenol—Asthenia—Carmustine—brain cancer	0.000214	0.00151	CcSEcCtD
Epoprostenol—PTGIR—Signaling Pathways—OR4C12—brain cancer	0.000214	0.00268	CbGpPWpGaD
Epoprostenol—PTGER1—Signaling Pathways—OR4C12—brain cancer	0.000214	0.00268	CbGpPWpGaD
Epoprostenol—PTGIR—Signaling Pathways—OR14C36—brain cancer	0.000214	0.00268	CbGpPWpGaD
Epoprostenol—PTGER1—Signaling Pathways—OR14C36—brain cancer	0.000214	0.00268	CbGpPWpGaD
Epoprostenol—Hypersensitivity—Temozolomide—brain cancer	0.000213	0.0015	CcSEcCtD
Epoprostenol—Paraesthesia—Etoposide—brain cancer	0.000207	0.00146	CcSEcCtD
Epoprostenol—Asthenia—Temozolomide—brain cancer	0.000207	0.00146	CcSEcCtD
Epoprostenol—Dyspnoea—Etoposide—brain cancer	0.000206	0.00145	CcSEcCtD
Epoprostenol—Somnolence—Etoposide—brain cancer	0.000205	0.00145	CcSEcCtD
Epoprostenol—Diarrhoea—Carmustine—brain cancer	0.000204	0.00144	CcSEcCtD
Epoprostenol—Pruritus—Temozolomide—brain cancer	0.000204	0.00144	CcSEcCtD
Epoprostenol—P2RY12—Platelet activation, signaling and aggregation—PIK3CG—brain cancer	0.000202	0.00254	CbGpPWpGaD
Epoprostenol—PTGIR—Hemostasis—TRPC6—brain cancer	0.000202	0.00253	CbGpPWpGaD
Epoprostenol—PTGER1—GPCR downstream signaling—ABR—brain cancer	0.000202	0.00252	CbGpPWpGaD
Epoprostenol—PTGIR—GPCR downstream signaling—ABR—brain cancer	0.000202	0.00252	CbGpPWpGaD
Epoprostenol—Decreased appetite—Etoposide—brain cancer	0.000201	0.00141	CcSEcCtD
Epoprostenol—PTGIS—Metabolism—CYP2C9—brain cancer	0.000201	0.00251	CbGpPWpGaD
Epoprostenol—Gastrointestinal disorder—Etoposide—brain cancer	0.000199	0.0014	CcSEcCtD
Epoprostenol—Fatigue—Etoposide—brain cancer	0.000199	0.0014	CcSEcCtD
Epoprostenol—P2RY12—Signaling by GPCR—ABR—brain cancer	0.000199	0.00249	CbGpPWpGaD
Epoprostenol—P2RY12—Signaling Pathways—DTX2—brain cancer	0.000198	0.00247	CbGpPWpGaD
Epoprostenol—Dizziness—Carmustine—brain cancer	0.000198	0.00139	CcSEcCtD
Epoprostenol—Pain—Etoposide—brain cancer	0.000198	0.00139	CcSEcCtD
Epoprostenol—Constipation—Etoposide—brain cancer	0.000198	0.00139	CcSEcCtD
Epoprostenol—Diarrhoea—Temozolomide—brain cancer	0.000198	0.00139	CcSEcCtD
Epoprostenol—Dizziness—Temozolomide—brain cancer	0.000191	0.00134	CcSEcCtD
Epoprostenol—Vomiting—Carmustine—brain cancer	0.00019	0.00134	CcSEcCtD
Epoprostenol—Gastrointestinal pain—Etoposide—brain cancer	0.000189	0.00133	CcSEcCtD
Epoprostenol—Rash—Carmustine—brain cancer	0.000188	0.00133	CcSEcCtD
Epoprostenol—Dermatitis—Carmustine—brain cancer	0.000188	0.00132	CcSEcCtD
Epoprostenol—Headache—Carmustine—brain cancer	0.000187	0.00132	CcSEcCtD
Epoprostenol—Vomiting—Temozolomide—brain cancer	0.000184	0.00129	CcSEcCtD
Epoprostenol—Urticaria—Etoposide—brain cancer	0.000184	0.00129	CcSEcCtD
Epoprostenol—PTGIR—Signaling by GPCR—ABR—brain cancer	0.000183	0.00229	CbGpPWpGaD
Epoprostenol—PTGER1—Signaling by GPCR—ABR—brain cancer	0.000183	0.00229	CbGpPWpGaD
Epoprostenol—Abdominal pain—Etoposide—brain cancer	0.000183	0.00129	CcSEcCtD
Epoprostenol—Body temperature increased—Etoposide—brain cancer	0.000183	0.00129	CcSEcCtD
Epoprostenol—Rash—Temozolomide—brain cancer	0.000182	0.00128	CcSEcCtD
Epoprostenol—Dermatitis—Temozolomide—brain cancer	0.000182	0.00128	CcSEcCtD
Epoprostenol—PTGIR—Signaling Pathways—DTX2—brain cancer	0.000182	0.00228	CbGpPWpGaD
Epoprostenol—PTGER1—Signaling Pathways—DTX2—brain cancer	0.000182	0.00228	CbGpPWpGaD
Epoprostenol—Headache—Temozolomide—brain cancer	0.000181	0.00127	CcSEcCtD
Epoprostenol—Nausea—Carmustine—brain cancer	0.000177	0.00125	CcSEcCtD
Epoprostenol—PTGIS—Disease—IDH1—brain cancer	0.000175	0.00219	CbGpPWpGaD
Epoprostenol—Nausea—Temozolomide—brain cancer	0.000171	0.00121	CcSEcCtD
Epoprostenol—PTGIS—Metabolism—BSG—brain cancer	0.000171	0.00214	CbGpPWpGaD
Epoprostenol—Hypersensitivity—Etoposide—brain cancer	0.00017	0.0012	CcSEcCtD
Epoprostenol—PTGIS—Disease—HEY1—brain cancer	0.000166	0.00208	CbGpPWpGaD
Epoprostenol—Asthenia—Etoposide—brain cancer	0.000166	0.00117	CcSEcCtD
Epoprostenol—P2RY12—Hemostasis—VAV1—brain cancer	0.000164	0.00206	CbGpPWpGaD
Epoprostenol—Pruritus—Etoposide—brain cancer	0.000163	0.00115	CcSEcCtD
Epoprostenol—PTGIS—Disease—DLL1—brain cancer	0.000163	0.00204	CbGpPWpGaD
Epoprostenol—Diarrhoea—Etoposide—brain cancer	0.000158	0.00111	CcSEcCtD
Epoprostenol—Dizziness—Etoposide—brain cancer	0.000153	0.00108	CcSEcCtD
Epoprostenol—PTGIR—Hemostasis—VAV1—brain cancer	0.000151	0.00189	CbGpPWpGaD
Epoprostenol—P2RY12—Signaling Pathways—PTCH2—brain cancer	0.00015	0.00188	CbGpPWpGaD
Epoprostenol—Vomiting—Etoposide—brain cancer	0.000147	0.00103	CcSEcCtD
Epoprostenol—PTGIS—Metabolism—IDH1—brain cancer	0.000147	0.00184	CbGpPWpGaD
Epoprostenol—Rash—Etoposide—brain cancer	0.000146	0.00103	CcSEcCtD
Epoprostenol—Dermatitis—Etoposide—brain cancer	0.000146	0.00102	CcSEcCtD
Epoprostenol—P2RY12—Signaling Pathways—HES5—brain cancer	0.000145	0.00182	CbGpPWpGaD
Epoprostenol—Headache—Etoposide—brain cancer	0.000145	0.00102	CcSEcCtD
Epoprostenol—P2RY12—Platelet activation, signaling and aggregation—IL2—brain cancer	0.000142	0.00178	CbGpPWpGaD
Epoprostenol—P2RY12—Signaling Pathways—STRADA—brain cancer	0.000141	0.00176	CbGpPWpGaD
Epoprostenol—P2RY12—GPCR downstream signaling—TRPC6—brain cancer	0.000139	0.00174	CbGpPWpGaD
Epoprostenol—PTGIS—Disease—ENO2—brain cancer	0.000139	0.00173	CbGpPWpGaD
Epoprostenol—PTGIS—Disease—SHH—brain cancer	0.000139	0.00173	CbGpPWpGaD
Epoprostenol—PTGIR—Signaling Pathways—PTCH2—brain cancer	0.000138	0.00173	CbGpPWpGaD
Epoprostenol—PTGER1—Signaling Pathways—PTCH2—brain cancer	0.000138	0.00173	CbGpPWpGaD
Epoprostenol—Nausea—Etoposide—brain cancer	0.000137	0.000966	CcSEcCtD
Epoprostenol—PTGIR—Signaling Pathways—HES5—brain cancer	0.000133	0.00167	CbGpPWpGaD
Epoprostenol—PTGER1—Signaling Pathways—HES5—brain cancer	0.000133	0.00167	CbGpPWpGaD
Epoprostenol—P2RY12—Signaling by GPCR—SHH—brain cancer	0.000131	0.00164	CbGpPWpGaD
Epoprostenol—PTGIR—Signaling Pathways—STRADA—brain cancer	0.00013	0.00162	CbGpPWpGaD
Epoprostenol—PTGER1—Signaling Pathways—STRADA—brain cancer	0.00013	0.00162	CbGpPWpGaD
Epoprostenol—PTGIR—GPCR downstream signaling—TRPC6—brain cancer	0.000128	0.0016	CbGpPWpGaD
Epoprostenol—PTGER1—GPCR downstream signaling—TRPC6—brain cancer	0.000128	0.0016	CbGpPWpGaD
Epoprostenol—P2RY12—Signaling by GPCR—TRPC6—brain cancer	0.000126	0.00158	CbGpPWpGaD
Epoprostenol—P2RY12—Signaling by GPCR—PTCH1—brain cancer	0.000124	0.00155	CbGpPWpGaD
Epoprostenol—P2RY12—Signaling by GPCR—SMO—brain cancer	0.000124	0.00155	CbGpPWpGaD
Epoprostenol—P2RY12—Platelet activation, signaling and aggregation—VEGFA—brain cancer	0.000121	0.00152	CbGpPWpGaD
Epoprostenol—PTGIR—Signaling by GPCR—SHH—brain cancer	0.00012	0.00151	CbGpPWpGaD
Epoprostenol—PTGER1—Signaling by GPCR—SHH—brain cancer	0.00012	0.00151	CbGpPWpGaD
Epoprostenol—PTGIS—Metabolism of lipids and lipoproteins—PIK3CG—brain cancer	0.000119	0.0015	CbGpPWpGaD
Epoprostenol—P2RY12—Signaling Pathways—ABR—brain cancer	0.000118	0.00147	CbGpPWpGaD
Epoprostenol—PTGIS—Metabolism—ENO2—brain cancer	0.000116	0.00145	CbGpPWpGaD
Epoprostenol—PTGIR—Signaling by GPCR—TRPC6—brain cancer	0.000116	0.00145	CbGpPWpGaD
Epoprostenol—PTGER1—Signaling by GPCR—TRPC6—brain cancer	0.000116	0.00145	CbGpPWpGaD
Epoprostenol—PTGER1—Signaling by GPCR—PTCH1—brain cancer	0.000114	0.00143	CbGpPWpGaD
Epoprostenol—PTGER1—Signaling by GPCR—SMO—brain cancer	0.000114	0.00143	CbGpPWpGaD
Epoprostenol—PTGIR—Signaling by GPCR—PTCH1—brain cancer	0.000114	0.00143	CbGpPWpGaD
Epoprostenol—PTGIR—Signaling by GPCR—SMO—brain cancer	0.000114	0.00143	CbGpPWpGaD
Epoprostenol—P2RY12—Signaling Pathways—GLI2—brain cancer	0.000113	0.00142	CbGpPWpGaD
Epoprostenol—PTGIR—Signaling Pathways—ABR—brain cancer	0.000108	0.00135	CbGpPWpGaD
Epoprostenol—PTGER1—Signaling Pathways—ABR—brain cancer	0.000108	0.00135	CbGpPWpGaD
Epoprostenol—P2RY12—Signaling Pathways—GLI1—brain cancer	0.000107	0.00134	CbGpPWpGaD
Epoprostenol—PTGIR—Signaling Pathways—GLI2—brain cancer	0.000104	0.00131	CbGpPWpGaD
Epoprostenol—PTGER1—Signaling Pathways—GLI2—brain cancer	0.000104	0.00131	CbGpPWpGaD
Epoprostenol—P2RY12—Hemostasis—PIK3CG—brain cancer	0.000104	0.00131	CbGpPWpGaD
Epoprostenol—P2RY12—GPCR downstream signaling—VAV1—brain cancer	0.000104	0.0013	CbGpPWpGaD
Epoprostenol—PTGER1—Gastrin-CREB signalling pathway via PKC and MAPK—EGFR—brain cancer	0.000103	0.00128	CbGpPWpGaD
Epoprostenol—P2RY12—Signaling Pathways—SUFU—brain cancer	0.000101	0.00127	CbGpPWpGaD
Epoprostenol—PTGIS—Disease—VAV1—brain cancer	0.0001	0.00125	CbGpPWpGaD
Epoprostenol—PTGER1—Signaling Pathways—GLI1—brain cancer	9.82e-05	0.00123	CbGpPWpGaD
Epoprostenol—PTGIR—Signaling Pathways—GLI1—brain cancer	9.82e-05	0.00123	CbGpPWpGaD
Epoprostenol—P2RY12—Signaling Pathways—GFAP—brain cancer	9.76e-05	0.00122	CbGpPWpGaD
Epoprostenol—PTGIR—Hemostasis—PIK3CG—brain cancer	9.61e-05	0.0012	CbGpPWpGaD
Epoprostenol—PTGIR—GPCR downstream signaling—VAV1—brain cancer	9.56e-05	0.0012	CbGpPWpGaD
Epoprostenol—PTGER1—GPCR downstream signaling—VAV1—brain cancer	9.56e-05	0.0012	CbGpPWpGaD
Epoprostenol—P2RY12—Signaling by GPCR—VAV1—brain cancer	9.43e-05	0.00118	CbGpPWpGaD
Epoprostenol—PTGIR—Signaling Pathways—SUFU—brain cancer	9.31e-05	0.00117	CbGpPWpGaD
Epoprostenol—PTGER1—Signaling Pathways—SUFU—brain cancer	9.31e-05	0.00117	CbGpPWpGaD
Epoprostenol—P2RY12—Signaling Pathways—HEY1—brain cancer	9.25e-05	0.00116	CbGpPWpGaD
Epoprostenol—P2RY12—Signaling Pathways—DLL1—brain cancer	9.07e-05	0.00114	CbGpPWpGaD
Epoprostenol—PTGER1—Signaling Pathways—GFAP—brain cancer	8.98e-05	0.00112	CbGpPWpGaD
Epoprostenol—PTGIR—Signaling Pathways—GFAP—brain cancer	8.98e-05	0.00112	CbGpPWpGaD
Epoprostenol—PTGIR—Signaling by GPCR—VAV1—brain cancer	8.68e-05	0.00109	CbGpPWpGaD
Epoprostenol—PTGER1—Signaling by GPCR—VAV1—brain cancer	8.68e-05	0.00109	CbGpPWpGaD
Epoprostenol—PTGIS—Disease—HES1—brain cancer	8.61e-05	0.00108	CbGpPWpGaD
Epoprostenol—PTGER1—Signaling Pathways—HEY1—brain cancer	8.51e-05	0.00107	CbGpPWpGaD
Epoprostenol—PTGIR—Signaling Pathways—HEY1—brain cancer	8.51e-05	0.00107	CbGpPWpGaD
Epoprostenol—PTGIR—Signaling Pathways—DLL1—brain cancer	8.35e-05	0.00105	CbGpPWpGaD
Epoprostenol—PTGER1—Signaling Pathways—DLL1—brain cancer	8.35e-05	0.00105	CbGpPWpGaD
Epoprostenol—PTGIS—Disease—PDGFRA—brain cancer	8.19e-05	0.00103	CbGpPWpGaD
Epoprostenol—P2RY12—Signaling Pathways—SHH—brain cancer	7.71e-05	0.000966	CbGpPWpGaD
Epoprostenol—P2RY12—Signaling Pathways—TRPC6—brain cancer	7.44e-05	0.000932	CbGpPWpGaD
Epoprostenol—P2RY12—Hemostasis—IL2—brain cancer	7.35e-05	0.00092	CbGpPWpGaD
Epoprostenol—P2RY12—Signaling Pathways—SMO—brain cancer	7.31e-05	0.000916	CbGpPWpGaD
Epoprostenol—P2RY12—Signaling Pathways—PTCH1—brain cancer	7.31e-05	0.000916	CbGpPWpGaD
Epoprostenol—PTGIS—Disease—IRS2—brain cancer	7.19e-05	0.000901	CbGpPWpGaD
Epoprostenol—PTGER1—Signaling Pathways—SHH—brain cancer	7.1e-05	0.000889	CbGpPWpGaD
Epoprostenol—PTGIR—Signaling Pathways—SHH—brain cancer	7.1e-05	0.000889	CbGpPWpGaD
Epoprostenol—PTGER1—Signaling Pathways—TRPC6—brain cancer	6.85e-05	0.000857	CbGpPWpGaD
Epoprostenol—PTGIR—Signaling Pathways—TRPC6—brain cancer	6.85e-05	0.000857	CbGpPWpGaD
Epoprostenol—PTGIR—Hemostasis—IL2—brain cancer	6.76e-05	0.000847	CbGpPWpGaD
Epoprostenol—PTGIR—Signaling Pathways—PTCH1—brain cancer	6.73e-05	0.000843	CbGpPWpGaD
Epoprostenol—PTGIR—Signaling Pathways—SMO—brain cancer	6.73e-05	0.000843	CbGpPWpGaD
Epoprostenol—PTGER1—Signaling Pathways—SMO—brain cancer	6.73e-05	0.000843	CbGpPWpGaD
Epoprostenol—PTGER1—Signaling Pathways—PTCH1—brain cancer	6.73e-05	0.000843	CbGpPWpGaD
Epoprostenol—P2RY12—GPCR downstream signaling—PIK3CG—brain cancer	6.6e-05	0.000826	CbGpPWpGaD
Epoprostenol—PTGIS—Disease—APC—brain cancer	6.35e-05	0.000796	CbGpPWpGaD
Epoprostenol—P2RY12—Hemostasis—VEGFA—brain cancer	6.24e-05	0.000782	CbGpPWpGaD
Epoprostenol—PTGER1—GPCR downstream signaling—PIK3CG—brain cancer	6.07e-05	0.00076	CbGpPWpGaD
Epoprostenol—PTGIR—GPCR downstream signaling—PIK3CG—brain cancer	6.07e-05	0.00076	CbGpPWpGaD
Epoprostenol—P2RY12—Signaling by GPCR—PIK3CG—brain cancer	5.99e-05	0.00075	CbGpPWpGaD
Epoprostenol—P2RY12—Signaling Pathways—NOTCH2—brain cancer	5.85e-05	0.000732	CbGpPWpGaD
Epoprostenol—PTGIR—Hemostasis—VEGFA—brain cancer	5.74e-05	0.00072	CbGpPWpGaD
Epoprostenol—P2RY12—Signaling Pathways—VAV1—brain cancer	5.57e-05	0.000698	CbGpPWpGaD
Epoprostenol—PTGIR—Signaling by GPCR—PIK3CG—brain cancer	5.51e-05	0.000691	CbGpPWpGaD
Epoprostenol—PTGER1—Signaling by GPCR—PIK3CG—brain cancer	5.51e-05	0.000691	CbGpPWpGaD
Epoprostenol—PTGIR—Signaling Pathways—NOTCH2—brain cancer	5.38e-05	0.000674	CbGpPWpGaD
Epoprostenol—PTGER1—Signaling Pathways—NOTCH2—brain cancer	5.38e-05	0.000674	CbGpPWpGaD
Epoprostenol—CYP2C9—Metabolism of lipids and lipoproteins—IDH1—brain cancer	5.32e-05	0.000667	CbGpPWpGaD
Epoprostenol—PTGIS—Metabolism—PIK3CG—brain cancer	5.32e-05	0.000667	CbGpPWpGaD
Epoprostenol—PTGIR—Signaling Pathways—VAV1—brain cancer	5.13e-05	0.000642	CbGpPWpGaD
Epoprostenol—PTGER1—Signaling Pathways—VAV1—brain cancer	5.13e-05	0.000642	CbGpPWpGaD
Epoprostenol—PTGIS—Disease—ERBB2—brain cancer	4.93e-05	0.000618	CbGpPWpGaD
Epoprostenol—P2RY12—Signaling Pathways—HES1—brain cancer	4.79e-05	0.0006	CbGpPWpGaD
Epoprostenol—P2RY12—Hemostasis—TP53—brain cancer	4.72e-05	0.000591	CbGpPWpGaD
Epoprostenol—P2RY12—GPCR downstream signaling—IL2—brain cancer	4.64e-05	0.000581	CbGpPWpGaD
Epoprostenol—P2RY12—Signaling Pathways—PDGFRA—brain cancer	4.56e-05	0.000572	CbGpPWpGaD
Epoprostenol—P2RY12—Signaling Pathways—SPP1—brain cancer	4.43e-05	0.000555	CbGpPWpGaD
Epoprostenol—PTGIR—Signaling Pathways—HES1—brain cancer	4.41e-05	0.000553	CbGpPWpGaD
Epoprostenol—PTGER1—Signaling Pathways—HES1—brain cancer	4.41e-05	0.000553	CbGpPWpGaD
Epoprostenol—PTGIR—Hemostasis—TP53—brain cancer	4.34e-05	0.000544	CbGpPWpGaD
Epoprostenol—PTGIS—Disease—CTNNB1—brain cancer	4.32e-05	0.000541	CbGpPWpGaD
Epoprostenol—PTGER1—GPCR downstream signaling—IL2—brain cancer	4.27e-05	0.000535	CbGpPWpGaD
Epoprostenol—PTGIR—GPCR downstream signaling—IL2—brain cancer	4.27e-05	0.000535	CbGpPWpGaD
Epoprostenol—P2RY12—Signaling by GPCR—IL2—brain cancer	4.22e-05	0.000528	CbGpPWpGaD
Epoprostenol—PTGER1—Signaling Pathways—PDGFRA—brain cancer	4.2e-05	0.000526	CbGpPWpGaD
Epoprostenol—PTGIR—Signaling Pathways—PDGFRA—brain cancer	4.2e-05	0.000526	CbGpPWpGaD
Epoprostenol—PTGIR—Signaling Pathways—SPP1—brain cancer	4.08e-05	0.000511	CbGpPWpGaD
Epoprostenol—PTGER1—Signaling Pathways—SPP1—brain cancer	4.08e-05	0.000511	CbGpPWpGaD
Epoprostenol—P2RY12—Signaling Pathways—IRS2—brain cancer	4.01e-05	0.000502	CbGpPWpGaD
Epoprostenol—PTGER1—Signaling by GPCR—IL2—brain cancer	3.88e-05	0.000486	CbGpPWpGaD
Epoprostenol—PTGIR—Signaling by GPCR—IL2—brain cancer	3.88e-05	0.000486	CbGpPWpGaD
Epoprostenol—PTGIS—Disease—STAT3—brain cancer	3.76e-05	0.000471	CbGpPWpGaD
Epoprostenol—PTGIR—Signaling Pathways—IRS2—brain cancer	3.69e-05	0.000462	CbGpPWpGaD
Epoprostenol—PTGER1—Signaling Pathways—IRS2—brain cancer	3.69e-05	0.000462	CbGpPWpGaD
Epoprostenol—P2RY12—Signaling Pathways—PIK3CG—brain cancer	3.54e-05	0.000443	CbGpPWpGaD
Epoprostenol—P2RY12—Signaling Pathways—APC—brain cancer	3.54e-05	0.000443	CbGpPWpGaD
Epoprostenol—PTGIS—Disease—MYC—brain cancer	3.5e-05	0.000438	CbGpPWpGaD
Epoprostenol—PTGIS—Disease—EGFR—brain cancer	3.42e-05	0.000428	CbGpPWpGaD
Epoprostenol—PTGIR—Signaling Pathways—PIK3CG—brain cancer	3.26e-05	0.000408	CbGpPWpGaD
Epoprostenol—PTGER1—Signaling Pathways—APC—brain cancer	3.26e-05	0.000408	CbGpPWpGaD
Epoprostenol—PTGIR—Signaling Pathways—APC—brain cancer	3.26e-05	0.000408	CbGpPWpGaD
Epoprostenol—PTGER1—Signaling Pathways—PIK3CG—brain cancer	3.26e-05	0.000408	CbGpPWpGaD
Epoprostenol—P2RY12—Signaling by GPCR—EGFR—brain cancer	3.22e-05	0.000404	CbGpPWpGaD
Epoprostenol—PTGER1—Signaling by GPCR—EGFR—brain cancer	2.97e-05	0.000372	CbGpPWpGaD
Epoprostenol—PTGIR—Signaling by GPCR—EGFR—brain cancer	2.97e-05	0.000372	CbGpPWpGaD
Epoprostenol—P2RY12—Signaling Pathways—RELA—brain cancer	2.77e-05	0.000346	CbGpPWpGaD
Epoprostenol—CYP2C9—Metabolism—BSG—brain cancer	2.76e-05	0.000345	CbGpPWpGaD
Epoprostenol—P2RY12—Signaling Pathways—ERBB2—brain cancer	2.75e-05	0.000344	CbGpPWpGaD
Epoprostenol—PTGER1—Signaling Pathways—RELA—brain cancer	2.54e-05	0.000319	CbGpPWpGaD
Epoprostenol—PTGIR—Signaling Pathways—RELA—brain cancer	2.54e-05	0.000319	CbGpPWpGaD
Epoprostenol—PTGER1—Signaling Pathways—ERBB2—brain cancer	2.53e-05	0.000317	CbGpPWpGaD
Epoprostenol—PTGIR—Signaling Pathways—ERBB2—brain cancer	2.53e-05	0.000317	CbGpPWpGaD
Epoprostenol—P2RY12—Signaling Pathways—IL2—brain cancer	2.49e-05	0.000312	CbGpPWpGaD
Epoprostenol—P2RY12—Signaling Pathways—CCND1—brain cancer	2.43e-05	0.000304	CbGpPWpGaD
Epoprostenol—P2RY12—Signaling Pathways—CTNNB1—brain cancer	2.4e-05	0.000301	CbGpPWpGaD
Epoprostenol—CYP2C9—Metabolism—IDH1—brain cancer	2.37e-05	0.000297	CbGpPWpGaD
Epoprostenol—PTGER1—Signaling Pathways—IL2—brain cancer	2.29e-05	0.000287	CbGpPWpGaD
Epoprostenol—PTGIR—Signaling Pathways—IL2—brain cancer	2.29e-05	0.000287	CbGpPWpGaD
Epoprostenol—PTGIR—Signaling Pathways—CCND1—brain cancer	2.23e-05	0.00028	CbGpPWpGaD
Epoprostenol—PTGER1—Signaling Pathways—CCND1—brain cancer	2.23e-05	0.00028	CbGpPWpGaD
Epoprostenol—PTGER1—Signaling Pathways—CTNNB1—brain cancer	2.21e-05	0.000277	CbGpPWpGaD
Epoprostenol—PTGIR—Signaling Pathways—CTNNB1—brain cancer	2.21e-05	0.000277	CbGpPWpGaD
Epoprostenol—P2RY12—Signaling Pathways—VEGFA—brain cancer	2.12e-05	0.000265	CbGpPWpGaD
Epoprostenol—P2RY12—Signaling Pathways—STAT3—brain cancer	2.1e-05	0.000262	CbGpPWpGaD
Epoprostenol—PTGER1—Signaling Pathways—VEGFA—brain cancer	1.95e-05	0.000244	CbGpPWpGaD
Epoprostenol—PTGIR—Signaling Pathways—VEGFA—brain cancer	1.95e-05	0.000244	CbGpPWpGaD
Epoprostenol—P2RY12—Signaling Pathways—MYC—brain cancer	1.95e-05	0.000244	CbGpPWpGaD
Epoprostenol—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CG—brain cancer	1.93e-05	0.000242	CbGpPWpGaD
Epoprostenol—PTGIR—Signaling Pathways—STAT3—brain cancer	1.93e-05	0.000242	CbGpPWpGaD
Epoprostenol—PTGER1—Signaling Pathways—STAT3—brain cancer	1.93e-05	0.000242	CbGpPWpGaD
Epoprostenol—P2RY12—Signaling Pathways—EGFR—brain cancer	1.9e-05	0.000239	CbGpPWpGaD
Epoprostenol—CYP2C9—Metabolism—ENO2—brain cancer	1.87e-05	0.000235	CbGpPWpGaD
Epoprostenol—PTGIR—Signaling Pathways—MYC—brain cancer	1.79e-05	0.000224	CbGpPWpGaD
Epoprostenol—PTGER1—Signaling Pathways—MYC—brain cancer	1.79e-05	0.000224	CbGpPWpGaD
Epoprostenol—PTGER1—Signaling Pathways—EGFR—brain cancer	1.75e-05	0.00022	CbGpPWpGaD
Epoprostenol—PTGIR—Signaling Pathways—EGFR—brain cancer	1.75e-05	0.00022	CbGpPWpGaD
Epoprostenol—P2RY12—Signaling Pathways—TP53—brain cancer	1.6e-05	0.0002	CbGpPWpGaD
Epoprostenol—PTGIR—Signaling Pathways—TP53—brain cancer	1.47e-05	0.000184	CbGpPWpGaD
Epoprostenol—PTGER1—Signaling Pathways—TP53—brain cancer	1.47e-05	0.000184	CbGpPWpGaD
Epoprostenol—CYP2C9—Metabolism—PIK3CG—brain cancer	8.6e-06	0.000108	CbGpPWpGaD
